NPPA issued a notification regarding the fixation of the retail price of Escitalopram Oxalate IP eq. to Escitalopram 5 mg + Clonazepam IP 0.5 mg for M/s Windlas Biotech Ltd. (Manufacturer) & M/s Ipca Laboratories Ltd. (Marketer)

Jul 18, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on July 16, 2026, issued a notification regarding the fixation of the retail price of Escitalopram Oxalate IP eq. to Escitalopram 5 mg + Clonazepam IP 0.5 mg for M/s Windlas Biotech Ltd. (Manufacturer) & M/s Ipca Laboratories Ltd. (Marketer).

The following has been stated:-

•Each film-coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 5 mg + Clonazepam IP 0.5 mg for M/s Windlas Biotech Ltd. (Manufacturer) & M/s Ipca Laboratories Ltd. (Marketer), the retail price is 10.72 Rs.

[Notification No.: 19(5250)/2026/DP/NPPA/Div.III/14659/2026]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT